Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Elegen Cuts Pricing for ENFINIA™ DNA, Expanding Access to Next-Generation Cell-Free DNA Manufacturing
-
Redfin Report: D.C. Rents Up 2.7% in February Following 3 Months of Declines; Too Soon to Tell if Whether Federal Job Cuts Will Affect the Market
-
Estrella Immunopharma, Inc. (NASDAQ: ESLA) Receives Buy Rating With a Price Target of $14.00 From CB Capital Partners
-
isinwheel Promotes Eco-friendly Transportation Alternatives in North America with Spring Sale Kicked off
-
Arthrosi Therapeutics Completes Enrollment in Pivotal Phase 3 REDUCE 2 Trial of AR882 for the Treatment of Gout and Tophaceous Gout
-
ZAGG Launches Tough Keys USB-C Direct Connect Keyboard/Case Combo for iPad (A16) and iPad (10th Generation)
-
Alacrity Solutions Acquires InspectionConnection, Expanding Services in Property & Claims Insurance Industry
-
Headspace Announces Partnership With the U.S. Navy
-
Solo Brands, Inc. Fourth Quarter and Fiscal Year 2024 Financial Results To Be Released Wednesday, March 12, 2025
-
TTEC Earns Great Place to Work Certification in 15 Countries, Expanding Global Recognition
-
LifeMD to Participate in the KeyBanc Capital Markets Healthcare Forum
-
Oryzon Announces Publication of Study on Phelan-McDermid Syndrome (PMS) Patients, a Form of Autism, Paving the Way for a Novel Personalized Medicine Approach with Vafidemstat
-
Special Integrated Logistics Zone Company (SILZ) Announces Groundbreaking of Lenovo's New Manufacturing Facility at Riyadh Integrated
-
Pipelinersales Corporation Launches Pipeliner CRM Availability in AWS Marketplace
-
Phillips 66 Issues Letter to Shareholders
-
Arkose Labs Achieves Fourth Consecutive Year of ISO Certifications; Successfully Transitions to ISO 27001:2022 Standards
-
Okoora Launches FX360, a New Technology Redefining Financial Infrastructure
-
Avadel Pharmaceuticals to Present at Upcoming Investor Conferences
-
Lineage Cell Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update on March 10, 2025
-
Epirus Closes $250M Series D to Hyperscale Leonidas Production Capability for Critical Asset Protection
-
Box to Present at Investor Conference
-
FIS Tops Global Core Banking Technology Providers Ranking
-
DataBee®, a Comcast Company, Introduces Novel and Automated Way to Manage Risk Posed by Asset Exposure and Vulnerabilities
-
PATTISON Outdoor Expands Presence in Niagara Region With New Advertising Partnership With Niagara Transit
-
Ron Cardwell Appointed President, GenCell Inc. to Bolster Company's Primary Focus on U.S. Market
-
Smith Micro Schedules Teleconference to Announce Fourth Quarter and Fiscal Year 2024 Financial Results
-
72% of Training and L&D Professionals Cite Learner Engagement as Top Virtual Training Obstacle Despite Global Adoption
-
FOUNDATION SOURCE APPOINTS SUZANNE VAN STAVEREN TO BOARD OF DIRECTORS
-
Sernova Biotherapeutics Secures $1 Million Convertible Debt Financing
-
Rune Labs Launches AI and Personalized Coaching Care Management Service for Parkinson’s Disease
-
Tech Alpharetta Hosts TopGolf Classic in Partnership with Relevantz
-
Impossible Foods Introduces Impossible® Steak Bites – Its Meatiest Plant-Based Innovation
-
FOUR SEASONS HOTEL MIAMI INTRODUCES POOLSIDE ESCAPE CABANAS WITH FOOD AND BEVERAGE EXPERIENCES INSPIRED BY HBO ORIGINAL THE WHITE LOTUS SEASON 3
-
NV5 Awarded $5 Million Florida Department of Transportation Geotechnical Engineering and Materials Testing Contract
-
WeFi Technology Group Announces Elisa Vila as Chief Operating Officer, Americas
-
Verisma Welcomes Two New Board Members to Propel Strategic Growth
-
Agora Launches Conversational AI Engine for Seamless Voice AI Experiences
-
Best Buy Announces Regular Quarterly Cash Dividend
-
Wells Fargo Joins Operation HOPE’s Project Restore HOPE Los Angeles Initiative to Provide Financial Relief & Recovery Services for Residents & Businesses Impacted by LA Wildfires
-
ASSOULINE PRESENTS SANTO DOMINGO: A CAPTIVATING JOURNEY THROUGH HISTORY, ART, AND CULTURE
-
ALX Oncology Highlights Focused Evorpacept Development Plan, Clinical Progress and Corporate Updates at R&D Day Webcast Event
-
Lumata Health Secures $23 Million Series B to Expand Access and Adherence to Vision-Saving Care
-
OPAL Fuels Expands Fuel Station Services Business in Canada
-
Novo Nordisk introduces NovoCare® Pharmacy, lowering cost of all doses of FDA-approved Wegovy® (semaglutide) to $499 per month and offering easy home delivery for cash-paying patients
-
MaxIQ Secures $7.8M in Seed Funding to Reimagine the Customer Journey for B2B SaaS Platforms
-
Supreme Group Acquires Kadiko, Expanding Strategic and Creative Capabilities for Healthcare and Life Sciences
-
Sigyn CEO Note: Combating the Rising Threat of New Pandemic Viruses
-
GreenFirst Responds to U.S. Tariffs on Canadian Lumber
-
The Literacy Alliance Receives $140,000 in Grants from Comcast to Support Digital Skills Training and New Testing Center in Fort Wayne
-
Silence Therapeutics to Webcast Presentation at the Leerink Partners Global Healthcare Conference
